L

Lipella Pharmaceuticals
D

LIPO

2.81000
USD
-0.13
(-4.42%)
Market Open
Volume
4,302
EPS
-15
Div Yield
-
P/E
-1
Market Cap
3,397,062
News

Title: Lipella Pharmaceuticals Inc

Sector: Healthcare
Industry: Biotechnology
Lipella Pharmaceuticals Inc is a clinical-stage biotechnology company. The company is focused on developing new drugs by reformulating the active agents in existing generic drugs and optimizing these reformulations for new applications. The company's product candidates include LP-10, LP-310 and LP-410 which can be helpful in treatment of Hemorrahagic Cystitis, Oral Licen Planus and Oral Graft.